News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VIVUS, Inc. (VVUS) Diet Pill to be Covered by Express Scripts Inc.



12/21/2012 7:33:18 AM

Vivus Inc said its obesity drug Qsymia will now be covered by the largest U.S. pharmacy benefits manager Express Scripts Holding Co, giving more people access to the drug and reducing costs for patients. Express Scripts added Qsymia as a standard benefit option to its national formulary, which means patients will now pay about $50 to $60 as their co-payment on a monthly prescription of Qsymia, or about one-third of the retail price. The drug is currently available only through mail-order pharmacies for an average retail price of $160. Vivus's Chief Commercial Officer Mike Miller said last month that about 30 percent of patients receiving a Qsymia prescription did not buy the drug because of the cost. Vivus's shares rose 8 percent to a high of $14.71 in early trade on the Nasdaq.

Read at Reuters
Read at Seeking Alpha
Read at BusinessWeek


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES